Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Malignant Hyperthermia (NGS Panel and Copy Number Analysis) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 4 | 2 |
|
GeneDx United States | 12 | 10 |
|
Asper Biogene Asper Biogene LLC Estonia | 7 | 3 |
|
Comprehensive Metabolism NGS Panel Fulgent Genetics United States | 602 | 355 |
|
Fulgent Genetics United States | 186 | 61 |
|
Malignant Hyperthermia Susceptibility NGS Panel Fulgent Genetics United States | 6 | 2 |
|
ACMG Secondary Findings (Medically Actionable Genes, Including Cardio and Cancer) NGS Panel Fulgent Genetics United States | 177 | 59 |
|
Hypokalemic and Hyperkalemic Periodic Paralysis NGS Panel Fulgent Genetics United States | 14 | 5 |
|
Nondystrophic Myotonia NGS Panel Fulgent Genetics United States | 35 | 10 |
|
Malignant Hyperthermia: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 3 | 2 |
|
MALIGNANT HYPERTHERMIASUSCEPTIBILITY TYPE 5 Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
Malignant Hyperthermia Advanced Sequencing Evaluation Athena Diagnostics United States | 2 | 2 |
|
CeGaT GmbH Germany | 7 | 2 |
|
Fulgent Genetics United States | 3 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Fulgent Genetics United States | 1103 | 676 |
|
Fulgent Genetics United States | 259 | 112 |
|
CACNA1S-Related Malignant Hyperthermia Susceptibility GGA - Galil Genetic Analysis Israel | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.